We are live on ! Find out more
CCRN

Cross Country Healthcare
CCRN

Delisted

CCRN was delisted on the 20th of July, 2026.

161 hedge funds and large institutions have $489M invested in Cross Country Healthcare in 2025 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 43 increasing their positions, 66 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.55% more ownership

Funds ownership: 98.48%100.03% (+1.6%)

8% less funds holding

Funds holding: 175161 (-14)

15% less capital invested

Capital invested by funds: $577M → $489M (-$88.3M)

32% less first-time investments, than exits

New positions opened: 25 | Existing positions closed: 37

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

35% less repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 66

86% less call options, than puts

Call options by funds: $58K | Put options by funds: $410K

Holders
161
Holders Change
-14
Holders Change %
-8%
% of All Funds
2.16%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
25
Increased
43
Reduced
66
Closed
37
Calls
$58K
Puts
$410K
Net Calls
-$352K
Net Calls Change
-$438K
Name Holding Trade Value Shares
Change
Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$5.49M -$297K -17,296 -4%
D.E. Shaw & Co
27
D.E. Shaw & Co
New York
$4.79M -$3.49M -203,061 -39%
UBS Group
28
UBS Group
Switzerland
$4.56M +$3.02M +175,874 +135%
GCL
29
Glazer Capital LLC
New York
$3.94M +$4.54M +264,387 New
Squarepoint
30
Squarepoint
New York
$3.49M -$359K -20,886 -8%
WIC
31
Water Island Capital
New York
$3.37M -$2.44M -141,808 -39%
CL
32
CSS LLC
Illinois
$3.24M +$2.96M +172,062 +377%
YCM
33
Yakira Capital Management
Connecticut
$2.98M +$2.48M +144,329 +259%
Morgan Stanley
34
Morgan Stanley
New York
$2.8M -$2.55M -148,648 -44%
KIM
35
Kestrel Investment Management
California
$2.72M
Renaissance Technologies
36
Renaissance Technologies
New York
$2.61M +$1.49M +86,818 +98%
AA
37
ABC Arbitrage
France
$2.56M +$82.9K +4,823 +3%
PCM
38
Prelude Capital Management
New York
$2.22M -$845K -49,185 -25%
SEI Investments
39
SEI Investments
Pennsylvania
$2.12M -$14.2K -824 -0.6%
N
40
Nuveen
North Carolina
$2.12M -$81.6K -4,750 -3%
Bank of New York Mellon
41
Bank of New York Mellon
New York
$1.86M -$44.7K -2,600 -2%
Invesco
42
Invesco
Georgia
$1.81M -$427K -24,875 -17%
UBS AM
43
UBS AM
Illinois
$1.72M +$146K +8,490 +8%
Deutsche Bank
44
Deutsche Bank
Germany
$1.72M -$48.1K -2,797 -2%
JP Morgan Chase
45
JP Morgan Chase
New York
$1.62M +$1.39M +80,705 +291%
PCMI
46
Paradigm Capital Management Inc
New York
$1.6M
Russell Investments Group
47
Russell Investments Group
United Kingdom
$1.6M -$130K -7,578 -7%
GLF
48
Groupe la Francaise
France
$1.57M +$1.81M +105,159 New
Man Group
49
Man Group
United Kingdom
$1.52M +$1.75M +102,065 New
Millennium Management
50
Millennium Management
New York
$1.48M -$5.26M -306,246 -76%

CCRN Hedge Fund Activity: Q1 2025 in Review

161 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Cross Country Healthcare (CCRN) for Q1 2025, worth a combined $489M — down 15% from $577M a quarter earlier.

Sellers outnumbered buyers: 37 funds closed out of CCRN and 25 opened new positions — a net loss of 12 holders — while 66 trimmed existing stakes and 43 added.

The largest buyer was AllianceBernstein, adding an estimated $18.2M. The largest seller was Royce & Associates, exiting entirely with an estimated $21.3M sold.

  • 161 institutional investors held Cross Country Healthcare (CCRN) as of Q1 2025, down from 175 in Q4 2024.
  • Funds reported $489M of Cross Country Healthcare stock for Q1 2025, down 15% quarter-over-quarter.
  • 25 funds opened new Cross Country Healthcare positions in Q1 2025 and 37 closed out, a net change of -12 holders.
  • The largest Cross Country Healthcare buyer in Q1 2025 was AllianceBernstein, an estimated $18.2M added.
  • The largest Cross Country Healthcare seller in Q1 2025 was Royce & Associates, an estimated $21.3M sold.

Based on aggregated 13F filings for Q1 2025.